Solaris Endovascular Reports Exceptional 6-Month Results with Solaris DE at CIRSE 2026
Complete DEScover dataset demonstrates 92.7% overall TLPP and 79.9% overall ACPP at six months, with primary safety endpoint met DALLAS, TX, UNITED STATES, September 8, 2026 /EINPresswire.com/ -- ANVISA approves new 40-patient DEScover arm …